PURA New CBD Consumer Product Brand Following 4 Recent Acquisitions To Be Unveiled Next Week
Puration, Inc. (PURA) announced plans to unveil a new brand for its CBD product expansion on September 1, 2020, targeting a market worth $500 billion.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Puration, Inc. (PURA) announced plans to unveil a new brand for its CBD product expansion on September 1, 2020, targeting a market worth $500 billion. Recent revenue reached $1.6 million, with a gross profit of $471,000, and year-to-date sales grew by 48%. The company has acquired multiple CBD businesses, aiming to leverage its patented extraction technology. With a $5 million investment secured, PURA intends to develop a unified marketing strategy across diverse industries including pet products and sun care, ultimately tapping into a market opportunity exceeding $2 trillion.
Positive
- Recent revenue of $1.6 million and gross profit of $471,000.
- Year-to-date sales increased 48% year-over-year.
- Acquired multiple CBD businesses, expanding market reach.
- Secured a $5 million investment for acquisition efforts.
- Development of a unified brand strategy across five industries.
Negative
- None.
Details
News Market Reaction – PURA
The recorded move for PURA in the trading session of this news was +21.33%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DALLAS, Aug. 27, 2020 /PRNewswire/ -- Puration, Inc. (USOTC: PURA) today confirmed the company will reveal the new brand name behind its horizontal CBD consumer product expansion into a
The company's expansion plan is built on a solid base CBD beverage business. The company recently reported
In January of this year, PURA initiated an acquisition campaign to introduce a solution to the cannabis sector-wide challenge with access to capital by leveraging its own core competencies to acquire CBD infused beverage, edible and topical businesses.
PURA targets CBD product acquisitions that can be enhanced with PURA's patented technology. PURA owns a license to a U.S. Patented cannabis extraction process backed by extensive university medical research. The license, issued by NCM Biotech, is exclusive for beverages, edibles and cosmetics among other uses. NCM Biotech is focused on medical research and Puration has access to that research. See a recent research report on CBD extracts derived from NCM Biotech's patented extraction process: Journal of Cannabis Research.
Since launching the acquisition campaign in January, the company has acquired a CBD confections business, a CBD pet products business and CBD sun care business. Combined with its existing beverage industry product line, PURA's combined horizontal market opportunity ranges across over
Sexual wellness
Confections
Pet Products
Sun Care
Non-Alcoholic Beverage
In conjunction with the acquisition campaign, PURA secured a
PURA is developing a single brand name identity and unified marketing strategy that can cross all five industries listed above in addition to any new industries PURA may enter with future acquisitions.
For more information on Puration, visit http://www.purationinc.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
View original content:http://www.prnewswire.com/news-releases/pura-new-cbd-consumer-product-brand-following-4-recent-acquisitions-to-be-unveiled-next-week-301119752.html
SOURCE Puration, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.